Official 2024 U.S. DOL Form 5500 summary for Lewis Drugs, INC. (Lewis Drugs, INC. 401(k) Plan · EIN 46-0212323 · PN 001): $56.07M net assets, 1,258 active participants, and $32.70 per $10,000 (32.70 bps).
| Plan Sponsor | Lewis Drugs, INC. |
|---|---|
| Filing Identifier | Lewis Drugs, INC. 401(k) Plan · EIN 46-0212323 · PN 001 |
| Plan Category & State | 401(k) Defined Contribution (SD) |
| Asset-Size Peer Cohort | $25M-$100M |
| Plan Net Assets (2024) | $56.07M |
| Active Participants | 1,258 |
| Direct Admin Fee Rate | $32.70 per $10,000 (32.70 bps) |
| Cohort Peer Median | $19.23 per $10,000 (19.23 bps) |
| Primary Recordkeeper / Provider | Morgan Stanley |
| Schedule H Line 4a Remittance | Schedule H Line 4a Late Remittance Reported ($99,423, often administrative timing) |
Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI